% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • beachinv beachinv Apr 26, 2013 9:19 AM Flag


    As I said before the stock market is really a function of supply and demand. We can't control how much others want the stock but we can affect the supply as their is a finite quantity of shares available. Hold tight to your shares until you see the full valuation of this drug platform. The manipulators have controlled this stock for last 3 yrs by preying on fears/rumors - this was trading closer to $14 less than 2yrs ago before the BS about safety/clinical hold. We knew that was not true and this has been confirmed with FDA lifting the hold and subsequent dog safety studies. The shorts/funds that wanted to steal shares used these fears to drive the stock even to below $3 last summer. Now we can see how they manipulate stock to their adavntage and get your shares. As for valuation, I think at a minimum this platform should currently be valued closer to $500-$700 MM mkt cap. Once the ph3 clinical trials in CF come out - you will see the validation of the drug platform and analysts and investors look at the mkt for both CF and NTM - then it is my feeling that we will see a rapid increase in valuation $1B plus as there are other applications in pulmonary and other settings using this technology. I have also said that it will be obvious when the institutions come for your shares - like going through eye of needle when shares are not available for sale. I say that we have been screwed for years in the valuation of this company - now that we are closer to catalysts/validation lets turn the tables on the manipulators and make them pay fair value for the shares....=) Apologize in advance for the long msg.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
14.00-0.06(-0.43%)Oct 26 4:00 PMEDT